Enhanced estimates of the influenza vaccination effect in preventing mortality a prospective cohort study

Medicine (United States)

Volumn 94, Issue 30, 2015, Pages

  Castilla, Jesus ^a   Guevara, Marcela ^a   Martinez Baz, Ivan ^b   Ezpeleta, Carmen ^b   Delfrade, Josu ^c   Irisarri, Fatima ^c   Moreno Iribas, Conchi ^d  

^a INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Instituto de Investigación Sanitaria de Navarra   (Spain)

^d Navarrabiomed Fundación Miguel Servet Red de Investigación en Servicios de Salud en Enfermedades Crónicas REDISSEC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

AGE; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FLU LIKE SYNDROME; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION PREVENTION; INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; PANDEMIC; PATIENT ATTITUDE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEASONAL INFLUENZA; SPAIN; VACCINATION; VERY ELDERLY; CAUSE OF DEATH; CLINICAL TRIAL; FOLLOW UP; HEALTH SURVEY; INFLUENZA, HUMAN; MULTICENTER STUDY; PANDEMICS; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TRENDS; UTILIZATION;

AGED; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PANDEMICS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; SPAIN; SURVIVAL RATE; VACCINATION;

EID: 84942420023     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001240     Document Type: Article

References (34)

1. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev. 1982;4:25-44
2. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179-186
3. Reichert TA, Simonsen L, Sharma A, et al. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol. 2004;160:492-502
4. Fifty-sixth World Health Assembly. Prevention and control of influenza pandemics and annual epidemics. Resolution 56.19 May 2003. http://apps.who.int/gb/archive/pdf-files/WHA56/ea56r19.pdf. Accessed: July 14, 2015
5. Nichol KL, Nordin JD, Nelson DB, et al. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007;357:1373-1381
6. Nichol KL, Margolis KL, Wuorenma J, et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994;331:778-784
7. Vu T, Farish S, Jenkins M, et al. A meta-Analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine. 2002;20:1831-1836
8. Voordouw BC, van der Linden PD, Simonian S, et al. Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-Associated morbidity. Arch Intern Med. 2003;163:1089-1094
9. Fedson DS, Wajda A, Nicol JP, et al. Clinical effectiveness of influenza vaccination in Manitoba. JAMA. 1993;270:1956-1961
10. Nelson JC, Jackson ML, Weiss NS, et al. New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol. 2009;62:687-694
11. Jackson LA, Jackson ML, Nelson JC, et al. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol. 2006;35:337-344
12. Jackson LA, Nelson JC, Benson P, et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol. 2006;35:345-352
13. Simonsen L, Taylor RJ, Viboud C, et al. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis. 2007;7:658-666
14. Ortqvist A, Granath F, Askling J, et al. Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area. Eur Respir J. 2007;30:414-422
15. Jackson ML, Yu O, Nelson JC, et al. Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic. Am J Epidemiol. 2013;178:1327-1336
16. Fireman B, Lee J, Lewis N, et al. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol. 2009;170:650-656
17. Instituto de Salud Carlos III. Vigilancia de la Gripe en Espana. Temporada 2011-12. Sistema de Vigilancia de la Gripe en Espana. Madrid: Instituto de Salud Carlos III; 2012. Spanish. http://vgripe.isciii. es/gripe/documentos/20112012/InformesAnuales/Informe-GRIPE-Temporada-2011-12-v.3septiembre2012.pdf. Accessed: July 14, 2015
18. Instituto de Salud Carlos III. Informe de Vigilancia de la Gripe en Espana. Temporada 2012-2013. Sistema de Vigilancia de la Gripe en Espana. Madrid: Instituto de Salud Carlos III; 2013. Spanish. http://vgripe.isciii.es/gripe/documentos/20122013/InformesAnuales/Informe-Vigilancia-GRIPE-2012-13-18sep2013.pdf. Accessed: July 14, 2015
19. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361:1945-1962
20. Castilla J, Moran J, Martinez-Artola V, et al. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study. Vaccine. 2011;29:5919-5924
21. Castilla J, Martinez-Baz I, Martinez-Artola V, et al. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill. 2013;18:pii: 20388
22. Martinez-Baz I, Navascues A, Pozo F, et al. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus. Hum Vaccin Immunother. 2015;3:1626-1633
23. Aguilar I, Reyes M, Martinez-Baz I, et al. Use of the vaccination register to evaluate influenza vaccine coverage in seniors in the 2010/11 influenza season, Navarre, Spain. Euro Surveill. 2012;17:pii: 20154
24. Hottes TS, Skowronski DM, Hiebert B, et al. Influenza vaccine effectiveness in the elderly based on administrative databases: change in immunization habit as a marker for bias. PLoS One. 2011;6:e22618
25. Baxter R, Lee J, Fireman B. Evidence of bias in studies of influenza vaccine effectiveness in elderly patients. J Infect Dis. 2010;201:186-189
26. Kelly H, Attia J, Andrews R, et al. The number needed to vaccinate (NNV) and population extensions of the NNV: comparison of influenza and pneumococcal vaccine programmes for people aged 65 years and over. Vaccine. 2004;22:2191-2198
27. Castilla J, Godoy P, Dominguez A, et al. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Clin Infect Dis. 2013;57:167-175
28. Mazick A, Gergonne B, Nielsen J, et al. Excess mortality among the elderly in 12 European countries, February and March 2012. Euro Surveill. 2012;17:pii: 20138
29. Martinez-Baz I, Aguilar I, Moran J, et al. Factors associated with continued adherence to influenza vaccination in the elderly. Prev Med. 2012;55:246-250
30. Armstrong BG, Mangtani P, Fletcher A, et al. Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people. BMJ. 2004;329:660
31. Smeeth L, Thomas SL, Hall AJ, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351:2611-2618
32. Hung IF, Leung AY, Chu DW, et al. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. Clin Infect Dis. 2010;51:1007-1016
33. Nunes B, Viboud C, Machado A, et al. Excess mortality associated with influenza epidemics in Portugal, 1980 to 2004. PLoS One. 2011;6:e20661
34. Simonsen L, Spreeuwenberg P, Lustig R, et al. Global mortality estimates for the 2009 influenza pandemic from the GLaMOR project: a modelling study. PLoS Med. 2013;10:e1001558